Trial Profile
PHASE II TRIAL OF BORTEZOMIB (VELCADE) IN COMBINATION WITH CHLORAMBUCIL IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTROM'S MACROGLOBULINEMIA OR SMALL LYMPHOCYTIC LYMPHOMA. A MULTICENTER STUDY.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 14 Jun 2011
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Chlorambucil
- Indications Chronic lymphocytic leukaemia; Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 14 Jun 2011 New trial record